Showing results (111-120 of 269) with videos related to

Sort By:
Pageof 27
Molecular Carcinogenesis|December 23, 2009
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogeneIsaia Barbieri, Elena Quaglino, Diego Maritano, et al.
International Journal of Cancer|March 5, 2016
Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imagingLorena Consolino, Dario Livio Longo, Walter Dastrù, et al.
Journal of Ultrasound|November 29, 2018
Prenatal and postnatal urinary tract dilation: advantages of a standardized ultrasound definition and classificationPiernicola Pelliccia, Simone Sferrazza Papa, Federica Cavallo, et al.
Oncotarget|April 23, 2016
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer modelAichi Msaki, Anna Pastò, Matteo Curtarello, et al.
International Journal of Molecular Sciences|June 13, 2025
Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome-Linked p63 Mutations Disrupt Keratinocyte Proliferation and Survival Through Oxidative Stress and Impaired Slc7a11 ExpressionDaniela Di Girolamo, Sara Palumbo, Dario Antonini, et al.
Plos One|February 26, 2013
ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult miceGiulia Ronchi, Giovanna Gambarotta, Federica Di Scipio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinomaArjen Sloots, Cristina Mastini, Florian Rohrbach, et al.
American Journal of Hematology|June 5, 2007
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patientsMaurizio Zangari, Dixie Esseltine, Federica Cavallo, et al.
Cancer|June 28, 2007
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapyAntonio Palumbo, Sara Bringhen, Patrizia Falco, et al.
Genome Biology|February 22, 2017
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cellsCarla Bosia, Francesco Sgrò, Laura Conti, et al.
Pageof 27